Latest Global Markets News

Kingsland Minerals is finalising its scoping study for the Leliyn Graphite Project, positioning itself to capitalise on shifting global graphite markets driven by new US tariffs on Chinese imports.

Microba Life Sciences reports record Q4 FY25 microbiome test sales in Australia and the UK, underpinned by landmark clinical studies and a $14.5 million capital raise. The company is transitioning away from legacy products to focus on high-value diagnostics, positioning for sustained growth in FY26.

Larvotto Resources has successfully raised US$105 million through a senior secured bond to fund the restart of its Hillgrove Gold-Antimony Project in New South Wales, targeting mining operations by mid-2026.

EVE Health Group has secured regulatory approval enabling prescription access for its lead products Libbo and Dyspro in Australia, setting the stage for a commercial rollout before the end of 2025.

Meteoric Resources has released a robust Pre-Feasibility Study for its Caldeira rare earths project in Brazil, highlighting a low-cost, long-life deposit with strong government backing and a targeted production start in 2028.

Patriot Battery Metals has announced a maiden Mineral Resource Estimate for the Rigel and Vega caesium zones at its Shaakichiuwaanaan Project, defining the world’s largest pollucite-hosted caesium deposit. This discovery positions the company as a potential key supplier of caesium, a critical mineral with rising demand in emerging solar technologies.

Tinybeans Group Limited has reported a second straight quarter of positive operating cash flow alongside steady subscriber growth and new product launches, signaling a turning point for the family-focused subscription platform.

IDT Australia has signed a memorandum with NASDAQ-listed Gelteq to establish a dedicated gel-based product manufacturing facility, marking a strategic expansion in pharmaceutical delivery technologies.

Future Generation Global has reported a strong 20.8% investment portfolio return for the year ending June 2025, prompting an increase in its fully franked interim dividend to 4.0 cents per share. This marks the sixth consecutive year of dividend growth for the ASX-listed investment company.

Western Yilgarn Limited announces a maiden JORC-compliant inferred mineral resource of 39.27 million tonnes at New Norcia, boosting its total bauxite portfolio to 244 million tonnes. The shallow, high-grade deposit benefits from strong infrastructure and promising metallurgical characteristics.

Syntara Limited has initiated dosing in its Phase 1c SATELLITE trial for a novel topical treatment targeting keloid scars, marking a significant step in addressing a $3.5 billion global market. The study, led by Professor Fiona Wood, will evaluate safety and early efficacy over three months.

Biome Australia Limited has reported a 69% increase in international sales revenue for FY25, reaching $1.5 million, driven by new strategic distribution agreements across Ireland, New Zealand, and Canada.